MoneyHero vs OptimizeRx
MNY and OPRX side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MNY and OPRX compare
MoneyHero grew revenue faster over the last twelve months (−7.7% versus −14.0% for OptimizeRx).
MoneyHero keeps more of each dollar of sales as profit, with a net margin of 7.1% compared with 5.3% at OptimizeRx.
OptimizeRx scores higher on the StockData Score (11 against 3 for MoneyHero), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MNY | OPRX |
|---|---|---|
| Size and price | ||
| Market cap | – | $138M |
| Share price | $0.610 | $7.34 |
| Change, 1 year | −56.4% | −54.6% |
| Change, 5 years | −93.9% | −89.8% |
| Beta (5Y) | 0.78 | 1.94 |
| Employees | 240 | 104 |
| StockData Score | ||
| Total score | 3 | 11 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 1 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 28.2× |
| P/S | – | 1.5× |
| P/B | – | 1.0× |
| EV/EBITDA | – | 8.2× |
| P/FCF | – | 7.0× |
| FCF yield | – | 14.4% |
| Fair value | – | $10.52 |
| Margin of safety | – | 30.2% |
| Growth | ||
| Revenue growth (TTM) | −7.7% (better) | −14.0% |
| Revenue growth, 5Y average | – | 20.4% |
| Net income growth (TTM) | −86.3% | 14656% (better) |
| Profitability | ||
| Gross margin | 49.2% | 75.3% (better) |
| Operating margin | −8.2% | 12.2% (better) |
| Net margin | 7.1% (better) | 5.3% |
| FCF margin | −14.1% | 21.1% (better) |
| Return on equity | – | 3.9% |
| Return on invested capital | – | 5.5% |
| Financial health | ||
| Debt / equity | – | 0.10 |
| Net debt / EBITDA | – | −0.61 |
| Interest coverage | −111.4× | 3.1× (better) |
| Current ratio | 2.02 | 5.06 (better) |
| Altman Z-score | – | 3.39 |
| Piotroski F-score | – | 8 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | – | 59.6% |
| Held by insiders | 10.7% | 19.4% |
| Insider net buying, 12 months | – | −$18.8K |
| Short interest, % of float | – | 7.8% |
Go deeper
- MNY stock overview
- MNY income statement
- MNY valuation and score
- OPRX stock overview
- OPRX income statement
- OPRX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.